HMN · Horace Mann Educators Corp /De/

The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.55 to $52.90.

Represents 217,395.305 vested restricted stock units and 97,234 shares of Common Stock.

The stock option exercise reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025, and this is an exercise and hold.

Represents 215,890.550 vested restricted stock units and 170,199 shares of Common Stock.

The stock option exercise reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025, and this is an exercise and hold.

Represents 215,890.550 vested restricted stock units and 162,345 shares of Common Stock.

Shares were withheld by the issuer in connection with a net exercise of stock options to satisfy the exercise price and applicable tax withholding obligations.

Represents 215,890.550 vested restricted stock units and 98,667 shares of Common Stock.

Shares were withheld by the issuer in connection with a net exercise of stock options to satisfy the exercise price and applicable tax withholding obligations.

Represents 215,890.550 vested restricted stock units and 104,734 shares of Common Stock.

The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.43.

Represents 215,890.550 vested restricted stock units and 91,921 shares of Common Stock.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 20, 2027.

Granted as compensation for services.

Represents 11,396.038 vested restricted stock units.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 20, 2027.

Granted as compensation for services.

Represents 22,173.129 vested restricted stock units and 3,237 shares of Common Stock.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 20, 2027.

Granted as compensation for services.

Represents 16,910 shares of Common Stock held directly.

The acquisition of Common Stock reported hereby is in the form of share-based restricted stock units which will vest in full on May 20, 2027.

Granted as compensation for services.

Represents 34,056.512 vested share-based restricted stock units and 8,808.174 deferred cash restricted stock units.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 20, 2027.

Granted as compensation for services.

Represents 26,812 shares of Common Stock held directly.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 20, 2027.

Granted as compensation for services.

Represents 17,534.307 vested restricted stock units and 499 shares of Common Stock.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 20, 2027.

Granted as compensation for services.

Represents 11,396.038 vested restricted stock units and 14,200 shares of Common Stock.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in full on May 20, 2027.

Granted as compensation for services.

Represents 24,943.654 vested restricted stock units and 3,237 shares of Common Stock.

The acquisition of Common Stock reported hereby is in the form of deferred cash restricted stock units pursuant to the 2010 Comprehensive Executive Compensation Plan as amended and restated.

Granted as compensation for services.

Represents 11,396.038 vested restricted stock units, 1,175.968 deferred cash restricted stock units and 14,200 shares of Common Stock.

The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.04 to $46.36.

Represents 215,890.550 vested restricted stock units and 99,421 shares of Common Stock.

The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in two transactions at $46.07 and $46.22.

Represents 215,890.550 vested restricted stock units and 99,435 shares of Common Stock.

The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.14.

Represents 215,890.550 vested restricted stock units and 99,437 shares of Common Stock.

The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.06 to $46.29.

Represents 215,890.550 vested restricted stock units and 99,840 shares of Common Stock.

The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.30.

Represents 215,890.550 vested restricted stock units and 100,106 shares of Common Stock.

The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on December 23, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.00 to $46.36.

Represents 215,890.550 vested restricted stock units and 106,921 shares of Common Stock.

The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025.

Represents 14,298.075 vested restricted stock units and 499 shares of Common Stock.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested.

Represents 3,687.139 vested restricted stock units, 7,644 shares of Common Stock, and 1,094 shares held in the Reporting Person's IRA.

The option vests in four equal annual installments beginning on March 4, 2027.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 4, 2027.

Represents 14,904.409 vested restricted stock units and 7,413 shares of Common Stock.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 4, 2027.

Represents 214,084.774 vested restricted stock units and 66,314 shares of Common Stock.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested.

Represents 3,825.559 vested restricted stock units and 20,556 shares of Common Stock.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 4, 2027.

The option vests in four equal annual installments beginning on March 4, 2027.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested.

Represents 21,050.197 vested restricted stock units and 7,413 shares of Common Stock.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 4, 2027.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 4, 2027.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested.

Represents 1,857.778 restricted stock units and 1,765.023 shares of Common Stock.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 4, 2027.

Represents 7,644 shares of Common Stock and 1,094 shares held in the Reporting Person's IRA.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested.

Represents 277,140.318 vested restricted stock units and 66,314 shares of Common Stock.

The option vests in four equal annual installments beginning on March 4, 2027.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which are fully vested.

Represents 2,677.407 vested restricted stock units and 15,976 shares of Common Stock.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 4, 2027.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 4, 2027.

The acquisition of Common Stock reported hereby is in the form of restricted stock units which will vest in three equal annual installments beginning March 4, 2027.

Represents 8,091.555 vested restricted stock units and 14,200 shares of Common Stock.

The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2024.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.93 to $46.29.

Represents 214,084.774 vested restricted stock units and 66,314 shares of Common Stock.

The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the reporting person on August 11, 2025.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.99 to $45.60.

Represents 14,178.481 vested restricted stock units and 1,580 shares of Common Stock.

Represents shares of Common Stock that the reporting person donated as a gift to a donor advised fund.

Represents 37,165.375 vested share-based restricted stock units, 11,754.477 deferred cash restricted stock units and 5,399.304 shares of Common Stock.

The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2024.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.02 to $45.80.

Represents 212,474.422 vested restricted stock units and 71,314 shares of Common Stock.

Represents 8,668.799 deferred cash restricted stock units and 30,332.596 vested share-based restricted stock units.